 | Up a level |
La Manna, F.; Staender, L.; Gray, P. C.; Zoni, E.; Karkampouna, S.; Thalmann, G. N.; Kruithof-de Julio, M. (15 March 2019). Cripto blockade reduces prostate cancer reactivity to microenvironment and metastatic potential. European Urology Supplements, 18(1), e1156-e1156. Elsevier 10.1016/S1569-9056(19)30833-4
